Great West Life Assurance CO Kodiak Sciences Inc. Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$7.57 - $12.5 $13,080 - $21,600	1,728 New	1,728 $13,000
Q2 2021 Aug 11, 2021	SELL	$77.2 - $126.54 $22,774 - $37,329	-295 Reduced 14.58%	1,728 $160,000
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $28,827 - $42,926	-261 Reduced 11.43%	2,023 $227,000
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $59,138 - $149,871	973 Added 74.22%	2,284 $334,000
Q3 2020 Nov 17, 2020	SELL	$45.05 - $59.27 $26.3 Million - $34.7 Million	-584,867 Reduced 99.78%	1,311 $77,000
Q3 2020 Nov 13, 2020	BUY	$45.05 - $59.27 $26.3 Million - $34.7 Million	584,867 Added 44612.28%	586,178 $34.7 Million
Q2 2020 Aug 17, 2020	BUY	$42.74 - $66.25 $1,196 - $1,855	28 Added 2.18%	1,311 $70,000
Q4 2019 Feb 11, 2020	BUY	$13.9 - $76.65 $17,833 - $98,341	1,283 New	1,283 $92,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.